fbpx An ECDC report on seasonal influenza vaccination | Scienza in rete

An ECDC report on seasonal influenza vaccination

Primary tabs

Read time: 2 mins

The European Centre for Disease Prevention and Control (ECDC) recently released a technical report in support of the Council Recommendation on seasonal influenza vaccination that the European Union (EU) Council adopted in December 2009. Aim of this Recommendation was to ask for concerted action to be taken, at a European level, to mitigate the impact of seasonal influenza by encouraging vaccination among risk groups and healthcare workers.

The ECDC provided technical assistance to Member States on monitoring the current situation with seasonal influenza and influenza immunization, and this report comes from the gathering of a great part of such data. Specifically, the document provides data on vaccination policies and strategies, vaccination coverage, and barriers to vaccination for seasonal influenza in the EU/EEA countries, drawn from two primary sources: the annual survey by the VENICE project and a Supplementary Questionnaire developed and implemented by ECDC to collect additional data especially relevant to the Council Recommendation. The report also cites the four European projects – TELLME being the first of the list – related to seasonal influenza vaccination and funded by the Directorate-General for Research and Innovation or by the Executive Agency for Health and Consumers.

The analysis of the data collected led ECDC experts to conclude that, since 2009, Member States have made limited progress in achieving the aims outlined in the Council Recommendation on seasonal influenza vaccination, despite the fact that almost all countries reported having in place national and regional vaccination policies or strategies for seasonal influenza. While few of them managed to get close to the given targets, they represent a minority and, since the deadline for the aims outlined in the Council Recommendation is the 2014-15 influenza season, it seems unlikely that more than a handful of them will manage to reach them. Such perception that little or no progress is being made was reinforced by the lack of data on vaccination coverage for relevant categories such as people with chronic conditions and healthcare workers. However, the report recognizes that a majority of them are instituting national programmes and have identified steps that could be taken to improve vaccination coverage rates in the short term and to strengthen the infrastructure to enable steady gains in coverage over the longer term.


Scienza in rete è un giornale senza pubblicità e aperto a tutti per garantire l’indipendenza dell’informazione e il diritto universale alla cittadinanza scientifica. Contribuisci a dar voce alla ricerca sostenendo Scienza in rete. In questo modo, potrai entrare a far parte della nostra comunità e condividere il nostro percorso. Clicca sul pulsante e scegli liberamente quanto donare! Anche una piccola somma è importante. Se vuoi fare una donazione ricorrente, ci consenti di programmare meglio il nostro lavoro e resti comunque libero di interromperla quando credi.


prossimo articolo

Editing epigenetico: modificare l'espressione genica senza alterare il DNA

Un articolo pubblicato su Nature e firmato dai ricercatori del San Raffaele TIGET descrive una nuova forma di editing del genoma, che non agisce sulla sequenza di DNA ma sfrutta i meccanismi epigenetici per silenziare i geni d'interesse. La tecnica, testata su modelli animali, ha il vantaggio di non modificare in modo permanente il genoma, e apre la strada a nuove prospettive di ricerca e, in futuro, applicazioni cliniche.

Silenziare un gene. Perché? E come farlo in pratica? Il perché è abbastanza semplice: se si trova il modo di spegnere un gene, se ne può esplorare la funzione. E poi, almeno in teoria, un gene difettoso che finirebbe per codificare per una proteina anomala può farci ammalare; e allora, togliamolo di mezzo. Tutto risolto dunque. Un po’, ma solo un po’. Per adesso le due tecniche impiegate per silenziare stabilmente un gene (l’interferenza a RNA e l’uso di nucleasi artificiali) funzionano bene, ma hanno grandi limiti.